Terms: = Lung cancer AND JAK3, L-JAK, 3718, ENSG00000105639, P52333, JAKL, JAK-3, LJAK, JAK3_HUMAN AND Treatment
13 results:
1. Characterization of ERBB2 (HER2) Alterations in Metastatic Non-small Cell lung cancer and Comparison of Outcomes of Different Trastuzumab-based Regimens.
Waliany S; Wakelee H; Ramchandran K; Das M; Huang J; Myall N; Li C; Pagtama J; Tisch AH; Neal JW
Clin Lung Cancer; 2022 Sep; 23(6):498-509. PubMed ID: 35753988
[TBL] [Abstract] [Full Text] [Related]
2. Effects of Vitexin, a Natural Flavonoid Glycoside, on the Proliferation, Invasion, and Apoptosis of Human U251 Glioblastoma Cells.
Huang J; Zhou Y; Zhong X; Su F; Xu L
Oxid Med Cell Longev; 2022; 2022():3129155. PubMed ID: 35281458
[TBL] [Abstract] [Full Text] [Related]
3. Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.
Newell F; Pires da Silva I; Johansson PA; Menzies AM; Wilmott JS; Addala V; Carlino MS; Rizos H; Nones K; Edwards JJ; Lakis V; Kazakoff SH; Mukhopadhyay P; Ferguson PM; Leonard C; Koufariotis LT; Wood S; Blank CU; Thompson JF; Spillane AJ; Saw RPM; Shannon KF; Pearson JV; Mann GJ; Hayward NK; Scolyer RA; Waddell N; Long GV
Cancer Cell; 2022 Jan; 40(1):88-102.e7. PubMed ID: 34951955
[TBL] [Abstract] [Full Text] [Related]
4. Discovery of (2
Su Q; Banks E; Bebernitz G; Bell K; Borenstein CF; Chen H; Chuaqui CE; Deng N; Ferguson AD; Kawatkar S; Grimster NP; Ruston L; Lyne PD; Read JA; Peng X; Pei X; Fawell S; Tang Z; Throner S; Vasbinder MM; Wang H; Winter-Holt J; Woessner R; Wu A; Yang W; Zinda M; Kettle JG
J Med Chem; 2020 May; 63(9):4517-4527. PubMed ID: 32297743
[TBL] [Abstract] [Full Text] [Related]
5. Immediate Adaptation Analysis Implicates BCL6 as an EGFR-TKI Combination Therapy Target in NSCLC.
Zhou Tran Y; Minozada R; Cao X; Johansson HJ; Branca RM; Seashore-Ludlow B; Orre LM
Mol Cell Proteomics; 2020 Jun; 19(6):928-943. PubMed ID: 32234966
[TBL] [Abstract] [Full Text] [Related]
6. IL-7-Mediated IL-7R-jak3/STAT5 signalling pathway contributes to chemotherapeutic sensitivity in non-small-cell lung cancer.
Shi L; Xu Z; Yang Q; Huang Y; Gong Y; Wang F; Ke B
Cell Prolif; 2019 Nov; 52(6):e12699. PubMed ID: 31599032
[TBL] [Abstract] [Full Text] [Related]
7. cancer gene profiling in non-small cell lung cancers reveals activating mutations in JAK2 and jak3 with therapeutic implications.
Li SD; Ma M; Li H; Waluszko A; Sidorenko T; Schadt EE; Zhang DY; Chen R; Ye F
Genome Med; 2017 Oct; 9(1):89. PubMed ID: 29082853
[TBL] [Abstract] [Full Text] [Related]
8. A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the jak3/STAT3 signaling pathway.
Mao Y; Wang J; Zhang M; Fan W; Tang Q; Xiong S; Tang X; Xu J; Wang L; Yang S; Liu S; Xu L; Chen Y; Xu L; Yin R; Zhu J
Oncotarget; 2017 Feb; 8(7):10954-10965. PubMed ID: 28009988
[TBL] [Abstract] [Full Text] [Related]
9. Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity.
Uthaisar K; Vaeteewoottacharn K; Seubwai W; Talabnin C; Sawanyawisuth K; Obchoei S; Kraiklang R; Okada S; Wongkham S
Oncol Rep; 2016 Sep; 36(3):1435-46. PubMed ID: 27461717
[TBL] [Abstract] [Full Text] [Related]
10. Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group.
Vollbrecht C; Werner R; Walter RF; Christoph DC; Heukamp LC; Peifer M; Hirsch B; Burbat L; Mairinger T; Schmid KW; Wohlschlaeger J; Mairinger FD
Br J Cancer; 2015 Dec; 113(12):1704-11. PubMed ID: 26645239
[TBL] [Abstract] [Full Text] [Related]
11. Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study.
Pallis AG; Syrigos K; Kotsakis A; Karachaliou N; Polyzos A; Chandrinos V; Varthalitis I; Christophyllakis C; Ardavanis A; Vamvakas L; Vardakis N; Saridaki Z; Samonis G; Giassas S; Georgoulias V; Agelaki S
Clin Lung Cancer; 2011 Mar; 12(2):100-5. PubMed ID: 21550556
[TBL] [Abstract] [Full Text] [Related]
12. The Src inhibitor AZD0530 blocks invasion and may act as a radiosensitizer in lung cancer cells.
Purnell PR; Mack PC; Tepper CG; Evans CP; Green TP; Gumerlock PH; Lara PN; Gandara DR; Kung HJ; Gautschi O
J Thorac Oncol; 2009 Apr; 4(4):448-54. PubMed ID: 19240653
[TBL] [Abstract] [Full Text] [Related]
13. Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells.
Verbsky JW; Bach EA; Fang YF; Yang L; Randolph DA; Fields LE
J Biol Chem; 1996 Jun; 271(24):13976-80. PubMed ID: 8662778
[TBL] [Abstract] [Full Text] [Related]
